IP, TRL and technology transfer

Convert research into commercially usable technology.

Invention screening, prior-art coordination, TRL assessment, prototype advancement, industry validation, licensing dossiers and technology-transfer support.

Outcome architecture
01Protect

Defensible invention route

02Advance

TRL evidence and prototype

03Validate

Industry need and adoption

The commercial reality

Patent count is not commercial value.

A useful portfolio connects technical novelty, ownership, performance evidence, user need, addressable market and a realistic transfer or venture route.

What the programme operates

From scattered work to accountable progression.

Every engagement has a defined stage, one owner, accepted evidence, visible decisions and a clear close condition.

01

IP formation

Structure invention disclosures, prior-art work, patentability assessment and drafting coordination.

02

TRL advancement

Define the present readiness level, missing proof and next validation milestone.

03

Commercial validation

Test user need, industry fit, partnership interest, licensing evidence and spinout route.

The operating sequence

The research-to-market chain

  1. 01

    Screen

    Novelty, ownership, readiness, use case and commercial potential.

  2. 02

    Protect

    Prior-art brief, patentability decision and coordinated filing route.

  3. 03

    Advance

    Prototype, test plan, evidence package and TRL reassessment.

  4. 04

    Transfer

    Industry validation, licensing dossier, venture or partnership action.

Outcome coverage

Technology-portfolio services

01Invention disclosure and patentability screening

02TRL baseline and advancement plan

03Prototype testing and evidence development

04Industry validation and technology-transfer support

Start with the next decision

Define one milestone. Make the route visible.

A first assessment clarifies feasibility, responsibility, evidence, timeline and the commercial scope before execution begins.

Start an assessment